Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. BNTX
BNTX logo

BNTX

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

BNTX News

Dividend Investment Opportunities in Pfizer and Bristol Myers Squibb

14h agoFool

BioNTech Plans to Shut Down German Manufacturing Sites

3d agoseekingalpha

Biotech M&A Surge Resumes with Major Deals

Jun 27 2026NASDAQ.COM

Pharmaceutical Sector Sees $65 Billion in M&A Activity in Q1 2023

Jun 27 2026Fool

Significant Transformation in Cancer Treatment

Jun 25 2026Newsfilter

Moderna Explores Manufacturing Investments in Germany

Jun 17 2026seekingalpha

Challenges and Opportunities in Neuro-Oncology

Jun 03 2026Newsfilter

First PD-(L)1xVEGF Bispecific Immunomodulator Shows Promising Efficacy in NSCLC

May 30 2026Newsfilter

Wall Street's Latest Rating Changes Overview

May 27 2026CNBC

BioNTech's Promising Clinical Data for Pumitamig and Gotistobart at ASCO 2026

May 22 2026Newsfilter

BioNTech Annual General Meeting Approves Key Resolutions

May 15 2026Newsfilter

Hantavirus Outbreak Sparks Rally in Biotech Stocks

May 13 2026Fool

Bristol Myers Squibb Faces Patent Cliff Challenges

May 12 2026Fool

Bristol Myers Squibb Faces Patent Cliffs Ahead

May 12 2026NASDAQ.COM

BioNTech Q1 2026 Earnings Call Insights

May 05 2026seekingalpha

BioNTech to Lay Off 1,860 Employees, Shift Focus to Oncology

May 05 2026seekingalpha